menu
    • menu

    Company profile for Liquidia Corporation

    NEW Drugs in Dev: 4
    Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients, & custom-made solutions to our customers.

    Virtual Booth

    Contact Supplier

    AbbVie Contract Manufacturing partners globally to develop, scale, and manufacture pharmaceutical products successfully.

    Virtual Booth

    Contact Supplier

    Topscience Biotech is a one-stop supplier of sodium hyaluronate//drug manufacturing license, CEP, GMP, DMF, and Form 41 certifications.

    Virtual Booth

    Contact Supplier

    Zach System is committed to providing Highly Customized Solutions for all your Development Programs.

    Virtual Booth

    Contact Supplier

    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Liquidia Corporation is a biopharmaceutical company focused on the development and commercialization of products in pulmonary hypertension and other applications of its PRINT® Technology. The company operates through its two wholly owned subsidiaries, Liquidia Technologies, Inc. and Liquidia PAH, LLC. Liquidia Technologies has developed YUTREPIA™ (treprostinil) inhalation powder for the treatment of pulmonary arterial hyper...
    Liquidia Corporation is a biopharmaceutical company focused on the development and commercialization of products in pulmonary hypertension and other applications of its PRINT® Technology. The company operates through its two wholly owned subsidiaries, Liquidia Technologies, Inc. and Liquidia PAH, LLC. Liquidia Technologies has developed YUTREPIA™ (treprostinil) inhalation powder for the treatment of pulmonary arterial hypertension (PAH). Liquidia PAH provides the commercialization for rare disease pharmaceutical products, such as generic Treprostinil Injection.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Liquidia CorporationUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    419 Davis Drive, Suite 100 Morrisville, NC 27560
    Telephone
    Telephone
    +1 919-328-4400
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://liquidia.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/liquidia-technologies
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/Liquidia_Inc

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    PEGS Boston Summit

    PEGS Boston Summit

    Not Confirmed

    envelop Contact Supplier

    PEGS Boston Summit

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Liquidia Announces Poster Presentations at the PHA 2026
    Liquidia Announces Poster Presentations at the PHA 2026

    11 Jun 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/06/11/3310462/0/en/liquidia-announces-poster-presentations-at-the-pha-2026-international-ph-conference-and-scientific-sessions.html

    GLOBENEWSWIRE
    11 Jun 2026
    Share Share
    Liquidia Corporation Added to S&P SmallCap 600 Index
    Liquidia Corporation Added to S&P SmallCap 600 Index

    08 Jun 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/06/08/3308109/0/en/Liquidia-Corporation-Announces-Inclusion-in-the-S-P-SmallCap-600-Index.html

    GLOBENEWSWIRE
    08 Jun 2026
    Share Share
    Liquidia Corporation to Present at Investment Conferences
    Liquidia Corporation to Present at Investment Conferences

    03 Nov 2025

    // PRESS RELEASE

    https://liquidia.com/news-releases/news-release-details/liquidia-corporation-present-upcoming-healthcare-investment

    PRESS RELEASE
    03 Nov 2025
    Share Share
    Liquidia Corporation Reports Q3 2025 Financial Results and Update
    Liquidia Corporation Reports Q3 2025 Financial Results and Update

    03 Nov 2025

    // PRESS RELEASE

    https://liquidia.com/news-releases/news-release-details/liquidia-corporation-reports-third-quarter-2025-financial

    PRESS RELEASE
    03 Nov 2025
    Share Share
    Liquidia Corporation to Report Q3 2025 Financial Results on Nov
    Liquidia Corporation to Report Q3 2025 Financial Results on Nov

    27 Oct 2025

    // PRESS RELEASE

    https://liquidia.com/news-releases/news-release-details/liquidia-corporation-report-third-quarter-2025-financial-results

    PRESS RELEASE
    27 Oct 2025
    Share Share
    Liquidia to Host R&D Day in New York City on October 28, 2025
    Liquidia to Host R&D Day in New York City on October 28, 2025

    07 Oct 2025

    // PRESS RELEASE

    https://liquidia.com/news-releases/news-release-details/liquidia-corporation-host-rd-day-new-york-city-october-28-2025

    PRESS RELEASE
    07 Oct 2025
    Share Share

    ABOUT THIS PAGE

    Contact Liquidia Corporation and get a quotation

    Liquidia Corporation is a supplier offers 1 products (APIs, Excipients or Intermediates).

    Find MOLD TEMPLATE FORMULATION 1 FOR PRINT® PROCESS bulk with DMF offered by Liquidia Corporation

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search